Recent advances in genomic research have revealed the existence of a large number of transcripts devoid of protein-coding potential in multiple organisms [1] [2] [3] [4] [5] [6] [7] [8] . Although the functional role for long noncoding RNAs (lncRNAs) has been best defined in epigenetic phenomena such as X-chromosome inactivation and imprinting, different classes of lncRNAs may have varied biological functions [8] [9] [10] [11] [12] [13] . We and others have identified a class of lncRNAs, termed ncRNA-activating (ncRNA-a), that function to activate their neighbouring genes using a cis-mediated mechanism 5,14-16 . To define the precise mode by which such enhancer-like RNAs function, we depleted factors with known roles in transcriptional activation and assessed their role in RNA-dependent activation. Here we report that depletion of the components of the co-activator complex, Mediator, specifically and potently diminished the ncRNA-induced activation of transcription in a heterologous reporter assay using human HEK293 cells. In vivo, Mediator is recruited to ncRNA-a target genes and regulates their expression. We show that ncRNA-a interact with Mediator to regulate its chromatin localization and kinase activity towards histone H3 serine 10. The Mediator complex harbouring disease-causing MED12 mutations 17, 18 displays diminished ability to associate with activating ncRNAs. Chromosome conformation capture confirmed the presence of DNA looping between the ncRNA-a loci and its targets. Importantly, depletion of Mediator subunits or ncRNA-a reduced the chromatin looping between the two loci. Our results identify the human Mediator complex as the transducer of activating ncRNAs and highlight the importance of Mediator and activating ncRNA association in human disease.
To define the transcriptional complex(es) that orchestrate the responsiveness of activating lncRNAs, we used HEK293 stable cell lines expressing the heterologous TK promoter driving luciferase expression fused to ncRNA-a7 (also called LINC00651) controlled by its own natural promoter and depleted factors known to be involved in transcriptional activation and enhancer function. We also developed stable lines expressing control reporters, in which a DNA fragment devoid of any transcriptional activity was substituted for the ncRNA-a7 genomic region ( Fig. 1a ). Importantly, depletion of ncRNA-a7 using two different short interfering RNAs (siRNAs) specifically decreased the transcription of the reporter construct containing ncRNA-a7 ( Fig. 1b ). Next, we depleted factors known to be involved in transcriptional activation ( Supplementary Fig. 1a ) and examined the responsiveness of cell lines harbouring the constructs expressing ncRNA-a7 or control constructs devoid of lncRNAs. Interestingly, only depletion of the Mediator subunit MED12 displayed a differential effect on the transcription of the reporter construct containing ncRNA-a7 ( Fig. 1c ). Depletion of other factors was either ineffective in changing transcriptional output (CDK9, CCNT1, NIPBL or WDR5) or reduced the transcriptional levels for both constructs (GTF2B, p300, SMC1) ( Fig. 1c ).
Mediator contains a complex and modular subunit composition 19, 20 . We depleted different components of Mediator corresponding to the head, middle or the tail modules and assessed their effect on the responsiveness of the cell lines harbouring the constructs driven by ncRNA-a7 or the control construct. Overall, depletion of other subunits of the Mediator complex also reduced the ncRNA-a7-induced activation, although there was also a small reduction in transcription of the control plasmid with depletion of some of the subunits ( Fig. 1d Supplementary Fig. 1b ). Similar to its effects on ncRNA-a7, depletion of the Mediator subunits decreased the RNA-induced activation of two other ncRNA-a, which were previously shown to regulate ECM1 and TAL1 genes ( Fig. 1e ). Taken together, these results identify the Mediator complex as a transducer of ncRNA-a function.
We next depleted the Mediator subunits and assessed their effect on ncRNA-a targets in vivo. We previously found that ncRNA-a7 and ncRNA-a3 regulate SNAI1 and TAL1 genes, respectively 5 . Moreover, using gene expression arrays, we had observed a profound decrease in AURKA transcription when ncRNA-a7 was depleted 5 . We confirmed these results by depleting ncRNA-a7 and ncRNA-a3, which led to a decrease in SNAI1, AURKA and TAL1 transcript levels using real-time PCR ( Fig. 2a, b ). We next depleted two different subunits of the Mediator complex, MED1 and MED12, and assessed the SNAI1, AURKA and TAL1 transcript levels ( Supplementary Fig. 1b ). Importantly, depletion of Mediator subunits decreased transcription of all three targets similar to that shown with depletion of ncRNA-a ( Fig. 2a, b , the affected genes are depicted by a black bar). Interestingly, depletion of Mediator subunits did not affect the transcript levels of genes that are not regulated by ncRNA-a (UBE2V1, CSTF, STIL, depicted by a white bar in Fig. 2a, b ). However, whereas ncRNA-a7 transcription was not affected after Mediator depletion, there was a decrease in ncRNA-a3 levels ( Fig. 2a, b ).
To ensure that such transcriptional effects after Mediator depletion were direct, we performed chromatin immunoprecipitation (ChIP) using antibodies against the MED12 and MED1 subunits of Mediator. This analysis revealed that the Mediator complex occupied the promoters of ncRNA-a3, ncRNA-a7 and their targets ( Fig. 2c, d ). Moreover, we found RNA polymerase II (RNAPII) at these promoters, consistent with Mediator occupancy (Fig. 2c, d) . Importantly, depletion of ncRNA-a7 or ncRNA-a3 decreased the occupancy of Mediator and RNAPII at their target genes without affecting the occupancy at genes not regulated by ncRNA-a ( Fig. 2c, d) . These results indicate that the Mediator complex occupies the promoters of genes regulated by ncRNA-a, and depletion of ncRNA decreases the occupancy of Mediator at these sites.
The Mediator complex, via its CDK8 module, displays kinase activity towards histone H3 serine 10 (H3S10), a histone modification with strong ties to transcriptional activation 21, 22 . We next assessed whether ncRNA-a regulate Mediator kinase activity towards histone H3. Addition of ncRNA-a7 or ncRNA-a3 led to a significant stimulation of the Mediator kinase activity towards histone H3, whereas the addition of primary let7b ncRNA or ncRNA HOTAIR had no effect ( Fig. 2e, f and Supplementary Fig. 2a ). Such stimulation of Mediator kinase activity by ncRNA-a was specific towards histone H3 as the substrate. We did not observe any stimulation when GST-CTD (corresponding to the C-terminal domain of RPB1) or cyclin H was used as substrates ( Supplementary Fig. 2b, c) . Moreover, consistent with a role for ncRNA-a in stimulation of histone H3 phosphorylation, depletion of ncRNA-a7 or ncRNA-a3 led to a specific decrease in H3S10 levels at SNAI1, AURKA and TAL1 ( Supplementary Fig. 2d and e).
We next asked whether ncRNA-a could associate with the Mediator complex. We isolated Mediator using stable cell lines expressing Flagepitope-tagged MED12 and examined its interaction with in-vitrotranscribed ncRNA-a7. An eluate from a stable Flag-GFP cell line was used as a control (Fig. 3a ). Whereas the control primary let7 transcript (pri-let7) or the ncRNA HOTAIR (a 429-nucleotide RNA with a similar base composition as ncRNA-a7) did not specifically interact with the Mediator complex, we detected a robust and specific association between ncRNA-a7 and the Mediator complex ( Fig. 3a) . Notably, Mediator also associated with ncRNA-a1 and ncRNA-a3, two other ncRNA-a that were shown to activate transcription of their neighbouring genes 5 (Fig. 3b ). 
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To assess the association of endogenous ncRNA-a and Mediator, the Flag-MED12 affinity-purified Mediator was fractionated by gel filtration and column fractions were subjected to western blot analysis and polymerase chain reaction with reverse transcription (RT-PCR) to detect the associated ncRNA-a ( Fig. 3c ). Whereas the HEK293 nuclear extract contained similar levels of ncRNA-a1, ncRNA-a3, HOTAIR and HOTTIP (HEK293 cells do not express ncRNA-a7; Supplementary Fig. 3a) , we could only detect ncRNA-a1 and ncRNA-a3 in association with the affinity-purified Mediator (Fig. 3c) . Indeed, ncRNA-a1 and ncRNA-a3 displayed a co-elution with components of the Mediator complex on gel filtration, further supporting their association with Mediator (Fig. 3c ). Next, we performed RNA immunoprecipitation following ultraviolet crosslinking (UV-RIP) with anti-MED12 antibodies or IgG, as control. Activating ncRNA-a1 and ncRNA-a3 were significantly enriched in the MED12 UV-RIP, whereas other abundant control messenger RNAs or non-coding RNAs such as GAPDH, HOTAIR, HOTTIP and XIST were not (Fig. 3d ). Two mutations in MED12 proteins have been linked to the development of the human genetic disorder Opitz-Kaveggia syndrome (also know as FG syndrome), causing physical anomalies and developmental delays 17, 18 (Fig. 3e) . Notably, whereas such mutations in MED12 do not affect its association with other Mediator subunits, they significantly diminish its association with ncRNA-a1 and ncRNA-a3 as measured by UV-RIP ( Fig. 3f, g) .
We next asked whether we could detect long-range chromatin looping between the ncRNA-a7 locus and its targets, SNAI1 and AURKA and whether ncRNA-a7 and the Mediator complex have a role in such an association. We performed chromosome conformation capture (3C) to assess the association of ncRNA-a7 with AURKA as well as SNAI1. We also performed a similar analysis between ncRNA-a3 and the TAL1 gene. We used anchoring points near the 39 untranslated region of ncRNA-a7 or ncRNA-a3 to measure the extent of chromatin looping between the ncRNA-a7 or ncRNA-a3 locus and their targets as shown in Fig. 4a, d and Supplementary Fig. 3b, c . This analysis revealed a strong association between the ncRNA-a7 locus and the region encompassing the promoter region of SNAI1 (Fig. 4b, upper panel) . e, Protein sequences of MED12 mutants causing FG syndrome. Part of the protein sequence of MED12 exon 21 is shown (top tow). The mutated sites indicate the G958E mutation (underlined) and the R961W mutation (underlined). f, HEK293T cells were transfected with Flag-MED12 or mutant constructs. After ultraviolet crosslinking, total cell extracts were immunoprecipitated and analysed by western blotting. g, After UV-RIP of wild-type and mutant MED12 samples shown in f, RT-qPCR was performed using transcript-specific primers from the lncRNAs shown. The data are representative of three independent experiments. The two-tailed Student's t-test indicated a P , 0.001 for ncRNA-a1 and ncRNA-a3, whereas there was no significant difference for HOTAIR and HOTTIP.
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Moreover, ncRNA-a7 also displayed an interaction with regions near the 59 end of the AURKA gene that extended into the body of the gene (Fig. 4c, upper panel) . There was no detectable association when a control anchor was placed in the genomic region between ncRNA-a7 and AURKA (Fig. 4b, c ). Next we depleted the Mediator subunits MED1 or MED12 and assessed their potential role in mediating the chromosomal looping between ncRNA-a7, SNAI1 and AURKA. Depletion of either MED1 or MED12 completely abrogated the chromosomal looping between ncRNA-a7 and SNAI1 (Fig. 4b, middle panel) . A similar result was obtained after depletion of MED1 or MED12 at the AURKA locus ( Fig. 4c, middle panel) . Importantly, depletion of ncRNA-a7 had a comparable effect, reducing the chromosomal looping between ncRNA-a7 and both SNAI1 and AURKA loci (Fig. 4b, c , lower panels). Because depletion of ncRNA-a7 using siRNAs resulted in a partial decrease of ncRNA-a7 concentration (about 60% depletion, Supplementary Fig. 1) , the residual ncRNA-a7 may be sufficient to promote smaller levels of DNA looping seen after ncRNA-a7 depletion.
We also performed a similar analysis measuring the extent of DNA looping between ncRNA-a3 and that of the TAL1 locus. Similar to results obtained with ncRNA-a7, we detected a specific and robust DNA looping between ncRNA-a3 and TAL1 (Fig. 4e ). Finally, depletion of Mediator subunits MED1 and MED12 or ncRNA-a3 nearly abolished the DNA looping between ncRNA-a3 and TAL1 (Fig. 4e , middle and lower panels). Notably, Mediator and ncRNA-a association with their target genes extend beyond the transcription start sites to include the more distal sites. This may reflect the engagement of proximal regulatory elements in ncRNA-a and Mediator chromatin looping (Fig. 4b, e ). These results suggest a mechanism of action for ncRNA-a and Mediator that may involve additional chromatin contacts beyond that which has been observed for distal regulatory elements and transcriptional start sites.
We propose a new mechanism of action for a class of lncRNAs termed ncRNA-activating (ncRNA-a) involved in long-range transcriptional activation through their association with the Mediator complex ( Supplementary Fig. 4 ). It is noteworthy that such Mediator-ncRNA-a-dependent chromatin loops extend beyond the transcription start sites of the target promoters, which may reflect the inclusion of promoter proximal regulatory elements in such associations. Future studies could also assess whether such ncRNA-a-Mediator chromatin loops augment, or function exclusively of, Mediator-Cohesin complexes 23 .
Recently, experiments in zebrafish uncovered a fundamental role for lncRNAs in developmental control 24 . Moreover, recent reports have linked a number of lncRNAs to human diseases such as cancer and neurological disorders 11, [25] [26] [27] . Importantly, our studies indicated that Mediator complexes containing disease-causing mutant MED12 proteins corresponding to FG syndrome fail to associate with ncRNAa. These results underscore the significance of Mediator-ncRNA-a association and suggest the loss of such Mediator-ncRNA-a interactions as a possible contributing factor in such developmental disorders.
METHODS SUMMARY
Depletion experiments using siRNA/DNA transfection and ncRNA luciferase assays. pGL3-TK-ncRNA-a and pGL3-TK-control constructs were generated as described previously. On-TargetPlus siRNAs and non-targeting control siRNA were purchased from Dharmacon. The Relative crosslinking frequencies Relative crosslinking frequencies Relative crosslinking frequencies Representative gel images of the 3C experiments for AURKA are presented in Supplementary Fig. 3 .
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performed with Lipofectamine RNAiMAX (Life Technologies) according to the manufacturer's instructions, using 50 nM siRNA/DNAs in a final volume of 2 ml of culture medium without antibiotics. Cells were collected 48-72 h after two rounds of transfection. Chromatin immunoprecipitation analysis was performed using 1 3 10 7 to 3 310 7 A549 or MCF7 cells were collected for each independent immunoprecipitation. After chemically crosslinking, cells were fixed in 1% formaldehyde 13PBS with 10% serum for 15 min at room temperature. After immunoprecipitation, bound chromatin was eluted at 65 uC for 10 min in 60 ml fresh elution buffer twice (TE, 1% SDS) and 80 ml of elution buffer was added to the final volume of 200 ml. Crosslinking samples were reversed overnight at 65 uC. After proteinase K treatment (0.5 mg ml 21 ), DNA was purified using a QIAquick PCR purification kit (Qiagen). Protein affinity purification and RNA immunoprecipitation. The affinitypurified mediator complex and the GFP protein control were generated from the Flag-tagged MED12 or GFP HEK293T stable cell lines. RNA probes, internally labelled with [a-32 P]CTP, were transcribed using T7 or Sp6 RNA polymerase (Riboprobe System, Promega). RNA immunoprecipitations were performed using Dynabeads Protein A (Invitrogen) according to the manufacturer's recommendations. Transient transfected HEK293T cells were UV-crosslinked at 254 nm (200 mJ cm 22 ) in 10 ml ice-cold PBS and collected by scraping. Cells were incubated in lysis solution (0.1% SDS, 0.5% NP40, 0.5% sodium deoxycholate, 400 U ml 21 RNase inhibitor (Roche)), and protease inhibitor at 4 uC for 25 min with rotation, followed by DNase treatment (30 U of DNase, 15 min at 37 uC).
Full Methods and any associated references are available in the online version of the paper.
